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Introduction 
Worldwide, breast cancer is the most prevalent cancer among women and 
impacting 2.3 million new cases (WHO, 2021).
In Malaysia, breast cancer affects 34.1% while 1 in 27 women likely to develop 
breast cancer in their lifetime (Azizah et al., 2019).
Referring to Clinical Practice Guideline for management of breast cancer in 
Malaysia, patients presenting with the breast symptoms should be evaluated 
with a full clinical examination, mammography and/or ultrasound followed by 
biopsy, either fine needle and/or core biopsy (Malaysia Ministry of Health, 
2010). 
There is still lack of research in Malaysia pertaining to the experiences of 
women with breast cancer specifically during the diagnostic interval. 
Objective 
To understand what are the experience of 
Malaysian women during the diagnostic 
interval of their breast cancer
Methods 
Design Qualitative, narrative approach 




2) diagnosed with primary breast cancer
3) 18 years old and above
4) able to speak Malay or English. 
Sample size 14 
Data 
collection
• Face-to-face, informal and unstructured interview using a piloted narrative 
script.
• Twelve interviews took place in the participants’ homes and 2 interviews at 
workplace. 
• Each interview lasted between 20 and 90 minutes (average 32 minutes). 
Data analysis • A narrative analysis by Riessman (1990
Ethical 
consideration
• Study participation was voluntary, and right to withdraw at any 
point of the study with no consequences. 
• Written consent was obtained from each participant prior to data 
collection.
• The interviews were recorded with participant’s permission
• Guaranteed confidentiality and anonymity of their data. 
Ethical 
approval 
1) Faculty of Health Sciences, University of Southampton (Ethics no: 
22983) 
2) Research Ethics Committee, Malaysia Ministry of Health 
Research and Ethics Committee (NMRR-16-1319-31877). 
Methods cont… 
Result 
Age 28 – 62 (mean: 46.1)


































Duration noticing symptom to first medical 
contact
< 1 week
1 week to < 1 month
1 month to <3 months
3 months to <6 months












Theme 1: Women who suspected having breast cancer 
Participant 6 said:
After that, I went to a government clinic. The doctor referred me to the hospital. 
I went to hospital X, checked with Dr. A. Then, on the same day, he immediately 
asked me to have a mammogram and ultrasound. The next week, he asked me 
to do MRI. The following week, I did biopsis [biopsy] … From the start, I could 
see that the doctor seemed like he was rushing to do the test. I felt like, like 
something was wrong. As usual practice, we tend to have late appointments, 
right, usually two to three weeks, but at that time, starting from the first day I 
met with the doctor, that doctor seemed to want to do many things. So, I 
expected something serious, like cancer.
Theme 2: Women who experienced false reassurance 
Participant 10 said:
The doctor said, “It’s nothing. Lymph nodes only.” S/he gave me 
medicine. S/he gave an antibiotic. I thought it was fine.
As consequences …
Participant 10 said:
Four to five months later, I realised that the thing had got 
bigger. I had already told the doctor. I was mad at that doctor. 
It was already quite big, 8cm.
Theme 3: Women who experienced delayed referral 
Participant 8 said: 
So, I went to the ordinary clinic taking a medication. It seemed okay. 
Then it [pain] happened again. Three times it happened. So, after it 
happened for a third time, the doctor asked me to go to a hospital, 
referred me to the hospital … during my first visit, the doctor gave 
Panadol. Second time, different painkiller.
Theme 4: Women who experienced inconclusive 
investigations result 
Participant 1 said: 
Two, three days after that, I went to the hospital again. Checked, 
checked, checked, checked. The doctor took, what is that called (p), 
took our meat (tissue) inside. Biopsy. Huh, biopsy. Two times she did 
it. At first, with the small needle. Cannot, unable to identify. The 
doctor did it again, on the following week. S/he did again. 
Discussion 
Even some women sought early medical consultation, it still took 1 to 3 months of 
undergoing diagnostic procedures before the diagnosis of breast cancer was confirmed. 
This interval was shorter compared to countries such as Libya (Ermiah et al., 2012) and 
Brazil (Soares et al., 2012), but it was longer when compared to Thailand (Poem et al., 2014).
In Malaysia, this situation occurred possibly due to lack of facilities and doctors, 
overcrowding and long waiting lists (Rasiah et al., 2010). 
Some of the women had experienced premature reassurance from the first medical doctor 
that they consulted. 
During diagnostic interval, the HCP appraisal process can be subjected to error and biases 
that may lead to misdiagnosis, dismissal of symptoms or no diagnosis (Scott et al., 2013). 
As a consequence of premature reassurance, these women in this study took about 4 
months to 1 year before they went back to see the doctor for the second time. 
This duration was almost the same as in a previous study, in which it was reported that 
false reassurance can persist for months and even years in relation to seeking help for 
subsequent cancer symptoms (Renzi et al., 2015).
Discussion cont …
In this study, one woman sought a medical consultation three times at the 
clinic, and it took more than a month before she was referred to the hospital 
for further investigation. 
The number of consultations is associated with an increased time from 
presentation to referral for cancer treatment (Lyratzopoulos et al., 2014). 
Some women had experienced unconfirmed diagnostic result.
Detection issues may relate to inherent features of the tumour or surrounding 
tissue, technical problems, or human error (Giess et al., 2012). 
Gandhi et al. (2006) found that 59% of diagnostic errors had three or more 
contributing process breakdowns, delaying diagnosis by more than 1 year on 
average.
Conclusion 
This study found that doctors’ action tended to result in both positive and 
negative consequences. 
Effort is required to minimise the potential risk of falsely reassuring patients. 
This can be accomplished by informing the patients about any uncertainty in 
the findings, explaining the symptom changes that need special attention, 
advising immediate help seeking behaviour if necessary and explaining the 
potential progress of the illness over time (Renzi et al., 2015). 
Simplicity in the diagnostic process is critical in limited-resource settings 
and they suggested that a combination of the many diagnostic tests 
available allows for the establishment of pathology diagnosis in one visit 
(Shyyan et al., 2006). 
Limitation & recommendation 
This study provides a basis for future research to gain healthcare provider’s 
perspectives that are directly involved during diagnostic interval. Their information 
could be then used to improve the early diagnosis of women with breast cancer. 
Even though the participants displayed a breadth of characteristics, including a 
variety in their stages of breast cancer, ethnicity, and age, this study focuses on 
patients that were engaged with medical services, but did not include the women 
who did not seek medical intervention and are continuing to ignore the symptoms. 
This study also focuses on specific setting that may not generalise to other 
population.  
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